Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)

M. Yamasaki, T. Yasuda, M. Yano, M. Hirao, K. Kobayashi, K. Fujitani, S. Tamura, Y. Kimura, H. Miyata, M. Motoori, O. Shiraishi, T. Makino, T. Satoh, M. Mori, Y. Doki

Research output: Contribution to journalArticlepeer-review

43 Citations (Scopus)

Fingerprint Dive into the research topics of 'Multicenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003)'. Together they form a unique fingerprint.

Medicine & Life Sciences